Kidtrayze

Zinc chloride, potassium iodide, sodium selenite, copper chloride dihydrate, manganese chloride tetrahydrate, the active ingredients in Kidtrayze, is a trace element supplement presented as a trace element supplement/injection for intravenous use. It addresses deficiencies of zinc, iodine, selenium, copper and manganese in patients requiring parenteral nutrition.

GNH USA supplies Kidtrayze as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Kidtrayze provides essential trace elements for patients with mineral deficiency disorders.

- Zinc deficiency: helps restore normal zinc concentrations and supports zinc‑dependent enzymatic activity. - Iodine deficiency: supplies iodine needed for thyroid hormone synthesis. - Selenium deficiency: contributes to antioxidant defenses and thyroid hormone metabolism. - Copper deficiency: supports copper‑dependent oxidases and iron metabolism. - Manganese deficiency: aids in bone formation and carbohydrate metabolism.

Kidtrayze may be associated with infusion‑related and systemic reactions.

Common Side Effects: - Infusion site pain or erythema. - Mild nausea or vomiting. - Transient headache. - Low‑grade fever. - Metallic taste. - Mild electrolyte imbalance.

Serious or Rare Side Effects: - Anaphylactic reaction. - Severe hypotension. - Acute renal impairment. - Marked electrolyte disturbances (e.g., hyper‑ or hypokalemia). - Hemolysis. - Severe hepatic dysfunction.

Kidtrayze should be used with careful clinical monitoring.

- Assess baseline trace element levels: obtain serum zinc, iodine, selenium, copper and manganese before initiation. - Monitor renal function: adjust therapy in patients with renal impairment. - Observe for infusion reactions: watch for signs of hypersensitivity during administration. - Avoid concurrent high‑dose mineral supplements: may lead to excess accumulation. - Pregnancy and lactation: administer only if clearly indicated and benefits outweigh risks. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Kidtrayze can interact with other agents that affect mineral balance or binding.

Major Interactions (Avoid): - High‑dose parenteral iron preparations: may precipitate trace elements and reduce efficacy. - Chelating agents (e.g., EDTA, dimercaprol): bind trace metals and diminish therapeutic effect. - Thyroid hormone therapy: excess iodine may alter hormone dosing.

Moderate Interactions (Monitor Closely): - Anticoagulants: copper may potentiate bleeding risk. - Renal dialysis: can remove administered trace elements, requiring dose adjustment.